We are live on
!
Find out more
MP
MSD Partners Portfolio holdings
AUM
$76.8M
1-Year Est. Return
34.91%
This Fund
S&P 500
This Quarter
Est. Return
-7.98%
1 Year Est. Return
-34.91%
3 Year Est. Return
+3.5%
5 Year Est. Return
-35.03%
10 Year Est. Return
+34.75%
AUM
$745M
AUM Growth
-$79.3M
(-9.6%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-15.25%
Top 10 Holdings %
Top 10 Hldgs %
90.76%
Holding
34
New
8
Increased
1
Reduced
2
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alaunos Therapeutics
TCRT
|
+$22M |
| 2 |
VCNX
Vaccinex, Inc. Common Stock
VCNX
|
+$6.57M |
| 3 |
iHeartMedia
IHRT
|
+$280K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$61.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$52.6M |
| 3 |
AGN
Allergan plc
AGN
|
+$13.4M |
| 4 |
BWX Technologies
BWXT
|
+$10.2M |
| 5 |
Marten Transport
MRTN
|
+$4.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 34.73% |
| 2 | Miscellaneous | 23.02% |
| 3 | Technology | 17.33% |
| 4 | Healthcare | 10.71% |
| 5 | Financials | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
iHeartMedia
IHRT
$435M
| $296K | 0.04% |
+19,704
| New | +$280K |
|
|
NBRV
27
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $100K | 0.01% |
200
| – | – |
|
|
28
BWX Technologies
BWXT
$14.4B
| – | – |
-196,542
| Closed | -$10.2M |
|
29
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| – | – |
-875,000
| Closed | -$37.4M |
|
|
30
PG&E
PCG
$31.5B
| – | – |
-2,676,554
| Closed | -$61.3M |
|
31
CALL
Shopify
SHOP
$187B
| – | – |
-75,000
| Closed | -$2.25M |
|
32
CALL
Tesla
TSLA
$1.4T
| – | – |
-712,500
| Closed | -$10.6M |
|
|
AGN
33
DELISTED
Allergan plc
AGN
| – | – |
-80,000
| Closed | -$13.4M |
|
|
RHT
34
DELISTED
Red Hat Inc
RHT
| – | – |
-280,000
| Closed | -$52.6M |
|
Similar funds
MA
PWS
QM
SWM
BC
VIM
SPC
SRA
MSD Partners's Q3 2019 Portfolio in Review
As of Q3 2019, MSD Partners held 34 positions worth $745M, down 9.6% from $825M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
MSD Partners withdrew a net $114M in Q3 2019, closing 7 positions and reducing 2 holdings. Its most notable exit was PG&E, an estimated $61.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 35% of assets, down from 36% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, MSD Partners opened a new position in Vaccinex, Inc. Common Stock worth $8.79M.
- MSD Partners's largest Q3 2019 buy was Vaccinex, Inc. Common Stock: 5,836 shares worth $8.79M.
- MSD Partners added most to Alaunos Therapeutics in Q3 2019, an estimated $22M increase.
- MSD Partners's biggest Q3 2019 reduction was Marten Transport, cutting an estimated $4.99M.
- MSD Partners fully exited PG&E in Q3 2019, selling an estimated $61.3M.
- MSD Partners's ten largest holdings make up 91% of its $745M portfolio in Q3 2019.
- MSD Partners opened 8 new positions and closed 7 in Q3 2019.
- MSD Partners's portfolio value fell 9.6% quarter-over-quarter to $745M.
Based on MSD Partners's 13F filing for Q3 2019, filed 14 Nov 2019.